Browse News
Filter News
Found 12 articles
-
Seres Therapeutics and Nestlé Health Science have announced a decision to team up for the joint commercialization of Seres’s investigational oral microbiome treatment for recurrent Clostridioides difficile infections.
-
FARE Launches Global Research Competition to Develop a Safe & Compassionate Diagnostic Test for Patients with Food Allergies
3/25/2021
$3 Million in Prize Money Inspires the World's Leading Food Allergy Researchers to Put an End to the Oral Food Challenge
-
Top 2020 Biopharma M&A Deals
1/6/2021
BioSpace highlights a number of the key M&A deals struck over the past 12 months. -
In August, Nestlé gobbled up Aimmune in a $2.6 billion deal, and now the food allergy-focused company will serve as the point pharmaceutical business for Nestlé Health Science.
-
Jayson Dallas, president and chief executive officer of Aimmune, said the agreement with Nestlé recognizes the value of Aimmune’s longtime commitment to advancing therapies for food allergies.
-
The add-on data showed that longer treatment with AR101 provided higher tolerance levels to peanut protein.
-
Nestlé Increases Stake in Aimmune as Company Eyes Filing for FDA Approval of Peanut Allergy Medicine
11/13/2018
As California-based Aimmune prepares to seek regulatory approval for its peanut allergy treatment, AR101, Nestlé Health Science has increased its financial stake in the food allergy prevention-focused company with another $98 million investment. -
Leading Companies Make Switch to Veeva OpenData to Deliver Accurate Data Faster to Field Teams
7/26/2018
Organizations from emerging biopharma to the largest pharmaceutical companies are improving field productivity and driving better customer engagement
-
NIH’s Baby Connectome Project Advances With Support From Wyeth Nutrition
7/6/2016
-
Nestle SA Extends Pharma Push by Contributing to Enterome's $16.5 Million Funding Round
4/20/2016
-
Medidata Solutions, Inc. And Nestle SA Partner On Mobile Health Study To Gauge Impact Of Nutrition Combined With Physical Activity In Healthy Aging Adults
3/10/2016
-
Nestle SA Pays $42.5 Million for Stake in Pronutria Biosciences
2/23/2016